Back

Phenotyping heart failure with a supranormal ejection fraction

23 May 2022 (17:41 - 17:50)
Organised by:
Congress Presentation Part of: Acute heartfailure from bench to bedside Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Mr Bart Johan Van Essen

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Coronary microvascular function in takotsubo syndrome
Doctor C. Ekenback (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Is heart failure associated with a worse prognosis than cancer? Five-year survival following hospitalization with heart failure.
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Circulating ketone bodies in patients with acute heart failure treated with the SGLT2 inhibitor empagliflozin
Ms S. Voorrips (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Distinct comorbidity clusters in patients with acute heart failure: data from RELAX-AHF-2
Miss K. Arevalo Gomez (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Hemodynamic impact of graded lower body negative pressure on left ventricular diastolic properties: a pressure volume study.
Mr L. Berboth (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heartfailure from bench to bedside
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 17:41 CET
You may be interested in
thumbnail
Congress Presentation
Hypercontractile phenotype of the left ventricle in patients with heart failure with preserved ejection fraction: too strong to be normal?
thumbnail
Congress Presentation
Echocardiographic characterization of patients with supranormal ejection fraction: pooled core laboratory analysis of the TOPCAT and PARAGON-HF trials
thumbnail
Congress Presentation
Heart failure with supranormal ejection fraction as a new HF phenotype. Clinical profile and prognosis of patients with based on the Heart Failure Observational Study of the Polish Cardiac Society

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources